Images from left to right; T1-weighted High Resolution Isotropic Volume...
Images from left to right; T1-weighted High Resolution Isotropic Volume Examination (THRIVE) pre-contrast agent injection used for perfusion assessment, diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) maps and fat channel in the water–fat-separated Dixon images for calculating lean tissue fraction (LTF). Top panels depict nondense breasts and bottom panels depict dense breasts.

Image source: Lundberg et al.; Bristish Journal of Cancer 2022 (CC BY 4.0)

News • Possible biological explanation found

Why are dense breasts associated with increased cancer risk?

The risk of developing breast cancer is higher in what are known as dense breasts, which appear white in mammograms, than in nondense breasts. Researchers at Linköping University (LiU) have now shown that there are major biological differences between dense breasts and nondense breasts.

The results, which were published in the British Journal of Cancer, suggest that the properties of dense breasts promote cancer growth. 

Not all breasts are the same in appearance or composition. Some breasts are “dense”, and the risk of developing cancer is five times higher in these than in nondense breasts. Mammography is regularly offered to all women in Sweden older than 40 years, while other methods used to detect tumours include magnetic resonance imaging (MRI) and ultrasound. The latter methods can be used as a supplement to mammography, but have not been evaluated for use in screening. Currently, dense and nondense breasts are treated in the same way in the Swedish healthcare system.

portrait of Charlotta Dabrosin
Professor Charlotta Dabrosin

Image source: LiU; photo: Peter Holgersson AB

“The problem is that we don’t know what to do with the women who have dense breasts. Large studies would be needed before introducing a screening programme for such women, such that we can identify those with greatest risk and follow them in the healthcare system. This is necessary to prevent putting many women through unnecessary examinations,” says Charlotta Dabrosin, professor in the Department of Biomedical and Clinical Sciences at Linköping University and consultant at the Oncology Clinic at Linköping University Hospital. 

The density of a breast mainly depends on the connective tissue, or to be more precise, on everything that is not fatty tissue, since the fraction of glandular tissue is approximately the same in all breasts, dense and nondense. In mammograms, both glandular tissue and connective tissue appear white. And cancer also appears white in mammograms. This means that it can be more difficult to detect cancerous changes in dense breasts by mammography. However, the difficulty of detecting a tumour does not fully explain the higher risk of cancer in women with dense breasts, and we do not at the moment know which other factors lie behind the increased risk. 

In the study, the researchers investigated whether the biological properties of dense and nondense breasts differ. For this, they developed an MRI method that can measure breast density and other distinguishing factors of breasts more accurately than current methods. Forty-four women, some with dense breasts and some with nondense breasts, were investigated using contrast-enhanced MRI. The researchers also used another technique, microdialysis. In this, a thin catheter is introduced into the breast tissue to obtain samples of the fluid that surrounds the cells, also known as the microenvironment. The researchers can measure the amounts of various proteins in this fluid. In previous studies, Charlotta Dabrosin has shown that the microenvironment in dense breasts is very similar to that in breast tumours.

We found, for example, that the contrast agent diffuses differently in the different types of breast, which suggests that the blood vessels are affected

Charlotta Dabrosin

The current study showed unexpectedly large differences between healthy dense and nondense breasts. The researchers measured the levels of 270 proteins and found that the levels of 124 of them were elevated in dense breasts. These proteins are associated with cancer development through such underlying processes as inflammation, the formation of new blood vessels, and cell growth. “There are huge biological differences between dense and nondense breasts. What I find amazing about our results is that we can link the levels of proteins such as inflammatory proteins and growth factors with the differences in breast physiology that we showed using MRI. We found, for example, that the contrast agent diffuses differently in the different types of breast, which suggests that the blood vessels are affected,” says Charlotta Dabrosin.

The researchers have seen only correlations, and cannot say what is cause and what is effect. The links between the amounts of protein and physiological differences are, however, so strong that the researchers believe that the links are causal. 

Approximately every third woman aged 40-50 has precursors to cancer in the breasts. The growth often remains at this stage, and fewer than 1% of women in this age group develop cancer. The researchers hypothesise that dense breasts have an advantageous microenvironment that promotes the transition of anomalous cells to cancer, which may be part of the explanation for the higher risk of cancer in dense breasts. “The results raise many questions about whether it is possible to reduce the levels of these proteins and reduce the risk of developing cancer. We open possibilities that we have not previously had,” says Charlotta Dabrosin. 

The researchers are now continuing their work with a clinical study of women with dense breasts, and will examine whether anti-inflammatory treatment can change the microenvironment in the breast. 


Source: Linköping University

03.11.2022

Read all latest stories

Related articles

Photo

News • Advanced techniques

Breast cancer: how imaging technology will help avoid unnecessary biopsies

Enhancing the diagnosis of breast cancer is the stated goal of a research team at the German Cancer Research Center (DKFZ) in Heidelberg. The scientists have combined an advanced method of…

Photo

Article • Screening

AB-MRI could be the ideal screening tool

MRI is increasingly relevant to cancer management, especially to detect breast carcinoma. Professor Christiane K Kuhl from the department of diagnostic and interventional radiology at the University…

Article •

Siemens opens Cologne research centre

Siemens Healthcare has opened a new research centre in Cologne, where around 40 employees are developing new diagnostic tests to describe the molecular characteristics of breast cancer cells, to help…

Related products

AB-CT – Advanced Breast-CT – nu:view

Mammo CT

AB-CT – Advanced Breast-CT – nu:view

AB-CT – Advanced Breast-CT GmbH
Fujifilm – Amulet Bellus II

Mammo Workstations

Fujifilm – Amulet Bellus II

FUJIFILM Europe GmbH
Fujifilm – AMULET Innovality

Tomosynthesis

Fujifilm – AMULET Innovality

FUJIFILM Europe GmbH
Fujifilm – AMULET Innovality Harmony

Tomosynthesis

Fujifilm – AMULET Innovality Harmony

FUJIFILM Europe GmbH
JVC – CL-S500

Displays – Mammo

JVC – CL-S500

JVCKENWOOD Deutschland GmbH
Siemens Healthineers – Mammomat Select

Film-Screen Mammography

Siemens Healthineers – Mammomat Select

Siemens Healthineers
Subscribe to Newsletter